HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jakub Fichna Selected Research

Trinitrobenzenesulfonic Acid

8/2021Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice.
5/2016Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.
1/2016Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice.
6/2015Experimental colitis in mice is attenuated by topical administration of chlorogenic acid.
10/2014Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jakub Fichna Research Topics

Disease

43Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2022 - 09/2013
40Inflammation (Inflammations)
01/2022 - 01/2014
35Colitis
02/2022 - 06/2012
25Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2022 - 08/2010
24Pain (Aches)
08/2021 - 02/2005
22Neoplasms (Cancer)
08/2022 - 12/2002
22Abdominal Pain (Pain, Abdominal)
04/2020 - 01/2012
21Crohn Disease (Crohn's Disease)
12/2021 - 06/2014
18Diarrhea
01/2022 - 07/2010
15Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 09/2014
14Ulcerative Colitis
08/2021 - 07/2014
13Constipation
03/2022 - 01/2015
11Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
03/2022 - 01/2012
10Visceral Pain
04/2020 - 01/2012
8Colonic Neoplasms (Colon Cancer)
02/2022 - 07/2014
6Carcinogenesis
08/2022 - 01/2016
5Ulcer
12/2020 - 01/2016
5Breast Neoplasms (Breast Cancer)
10/2009 - 08/2004
4Asthma (Bronchial Asthma)
02/2022 - 01/2016
4Body Weight (Weight, Body)
11/2021 - 10/2019
4Pancreatitis
10/2021 - 06/2019
3Obesity
01/2022 - 05/2018
3Colitis-Associated Neoplasms
01/2021 - 07/2014
3Multiple Sclerosis
01/2020 - 11/2012
2Idiopathic Pulmonary Fibrosis
02/2022 - 06/2021
2Fibrosis (Cirrhosis)
01/2022 - 08/2016
2Disease Progression
06/2021 - 01/2021
2Chronic Disease (Chronic Diseases)
03/2021 - 01/2020
2Nausea
01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

18Opioid Analgesics (Opioids)IBA
03/2022 - 08/2004
14Peroxidase (Myeloperoxidase)IBA
08/2021 - 06/2012
13Opioid Receptors (Opioid Receptor)IBA
03/2022 - 08/2004
11CytokinesIBA
03/2022 - 06/2014
9Dextran SulfateIBA
02/2022 - 01/2014
9Proteins (Proteins, Gene)FDA Link
06/2021 - 02/2005
8mu Opioid Receptors (mu Opioid Receptor)IBA
06/2017 - 08/2004
7morphiceptinIBA
10/2020 - 12/2002
6Analgesics (Analgesic Drugs)IBA
01/2021 - 01/2007
6Drinking WaterIBA
10/2020 - 10/2014
6CannabinoidsIBA
12/2019 - 01/2013
6Sulfonic AcidsIBA
01/2019 - 06/2012
5Castor Oil (Oil, Castor)IBA
01/2022 - 08/2014
5Fatty Acids (Saturated Fatty Acids)IBA
12/2021 - 01/2013
5AcidsIBA
12/2021 - 10/2015
5Nonesterified Fatty Acids (NEFA)IBA
11/2021 - 01/2020
5LigandsIBA
11/2021 - 08/2004
5Trinitrobenzenesulfonic AcidIBA
08/2021 - 10/2014
5Biomarkers (Surrogate Marker)IBA
06/2021 - 02/2016
5Dextrans (Dextran)FDA Link
03/2021 - 06/2012
5Peptides (Polypeptides)IBA
12/2020 - 01/2009
5SilverIBA
07/2020 - 01/2015
5Pharmaceutical PreparationsIBA
01/2020 - 01/2013
5EnzymesIBA
01/2018 - 11/2012
5Morphine (MS Contin)FDA LinkGeneric
01/2013 - 01/2007
4SolutionsIBA
05/2021 - 01/2012
4Neprilysin (Neutral Endopeptidase)IBA
12/2020 - 12/2016
4Estrogens (Estrogen)FDA Link
12/2020 - 01/2018
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2020 - 06/2012
4CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2019 - 12/2014
4Serotonin (5 Hydroxytryptamine)IBA
11/2019 - 10/2018
4EndocannabinoidsIBA
11/2019 - 01/2013
4BerberineIBA
10/2019 - 01/2014
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2022 - 03/2017
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2016
3Hormones (Hormone)IBA
12/2021 - 09/2013
3Naloxone (Narcan)FDA LinkGeneric
11/2021 - 02/2014
3LipidsIBA
11/2021 - 01/2016
3Messenger RNA (mRNA)IBA
06/2021 - 10/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 06/2014
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 12/2016
3Estrogen ReceptorsIBA
12/2020 - 01/2019
3GTP-Binding Proteins (G-Protein)IBA
06/2019 - 03/2015
3EnkephalinsIBA
02/2019 - 10/2014
3MelatoninIBA
01/2018 - 02/2014
3PolyphenolsIBA
01/2017 - 06/2015
3N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA
05/2016 - 02/2014
3Melatonin Receptors (Melatonin Receptor)IBA
05/2016 - 02/2014
3Narcotic Antagonists (Opioid Antagonists)IBA
02/2016 - 01/2009
3Opiate AlkaloidsIBA
06/2010 - 01/2007
2Tight Junction ProteinsIBA
03/2022 - 01/2017
2ChitinasesIBA
02/2022 - 06/2021
2GoldIBA
01/2022 - 03/2021
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2019
2Insulin (Novolin)FDA Link
01/2022 - 05/2018
2Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
12/2021 - 10/2017
2Glucagon-Like Peptides (Enteroglucagon)IBA
12/2021 - 11/2019
2Blood Glucose (Blood Sugar)IBA
12/2021 - 11/2019
2Indicators and Reagents (Reagents)IBA
10/2021 - 10/2019
2Arginine (L-Arginine)FDA Link
10/2021 - 10/2019
2Chlorogenic AcidIBA
10/2021 - 06/2015
2C-Reactive ProteinIBA
08/2021 - 03/2021
2SodiumIBA
03/2021 - 01/2017
2Peptide Hydrolases (Proteases)FDA Link
01/2021 - 10/2017
2MicroRNAs (MicroRNA)IBA
01/2021 - 12/2018
2sialorphinIBA
12/2020 - 01/2018
2Loperamide (Imodium)FDA LinkGeneric
09/2020 - 01/2020

Therapy/Procedure

36Therapeutics
02/2022 - 02/2010
4Drug Therapy (Chemotherapy)
01/2019 - 06/2015
3Biological Therapy
01/2020 - 06/2014
2Oral Administration
05/2021 - 03/2014